This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
iShares Nasdaq Biotechnology ETF
IBB : NASDAQ : Financial
$246.06 -2.10 | -0.83%
Today's Range: 240.03 - 252.51
Avg. Daily Volume: 2,028,700
02/09/16 - 11:54 AM ET
RETURN AND EXPENSE COMPARISON (as of Jan 2015)
IBB Return and Expenses Comparison Chart
1 Month: 2.01% 1 Year: 10.48%
3 Month: 7.25% 3 Year: 33.48%
6 Month: -8.63% 5 Year; 29.1%
Year-to-Date 10.48%    
Last Dividend
(12/24/2015)
$0.06    
Last Cap Gain 0.0    
Expense Ratio 0.48%    
RETURN AND VOLATILITY MEASURES
 1 Year3 Year
Alpha9.98%15.57%
Beta1.05%1.11%
R-squared38.0%32.0%
Standard Deviation22.65%21.03%
Semi-deviation4.75%3.35%
Definitions:
Alpha - measures the portfolio manager's contribution to performance that is independent of the benchmark.
Beta - measures the portfolio sensitivity to movements in the market relative to the selected underlying benchmark.
R-squared - mesausres how closely the derived forecast was able to explain the performance of the last three years. It also measures diversification with lower number indicating more independence from benchmark.
Standard deviation - measures how closely actual values matched the forecasted values for performance.
Semi-deviation - only considers values that fall below the risk free rate of return.
Top Ten Holdings
Amgen Inc 8.76%
Biogen Inc 8.44%
Celgene Corp 8.31%
Regeneron Pharmaceuticals Inc 8.25%
Gilead Sciences Inc 7.89%
Alexion Pharmaceuticals Inc 4.54%
Vertex Pharmaceuticals Inc 4.04%
Illumina Inc 3.98%
Incyte Corp 3.08%
Biomarin Pharmaceutical Inc 2.65%
MOST RECENT RATINGS CHANGES
Date Price Action From To
09/30/2014 $273.63 Upgrade HOLD BUY
08/31/2014 $276.55 Downgrade BUY HOLD


Sector Allocation
IBB Sector Allocation Chart
Basic Materials0.0%
Capital Goods0.0%
Technology0.0%
Consumer Staples0.0%
Healthcare89.29%
Energy0.0%
Finance0.0%
Transportation0.0%
Communication Services0.0%
Utilities0.0%
Miscellaneous0.03%
 

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs